Indication

Osteomalacia

Osteomalacia is a metabolic bone disorder characterized by the softening of the skeleton due to defective or delayed mineralization of newly formed organic bone matrix (osteoid) in mature, remodeling bone. Read more about Osteomalacia

112 drugs 69 manufacturers

Advertisement

Drugs that treat it

Common Osteomalacia therapies.

Showing 37–45 of 112 drugs

Filter & compare in the drug finder →Opens the drug finder with Osteomalacia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Osteomalacia.

Osteomalacia is a metabolic bone disorder characterized by the softening of the skeleton due to defective or delayed mineralization of newly formed organic bone matrix (osteoid) in mature, remodeling bone.

Primarily affecting adolescents and adults with closed growth plates, it most commonly arises from severe, prolonged vitamin D deficiency, abnormal vitamin D metabolism, or renal phosphate wasting.

The resulting accumulation of unmineralized osteoid impairs structural integrity, clinically presenting as diffuse bone pain, bone tenderness, proximal muscle weakness, a waddling gait, and an increased risk of fragility fractures and pseudofractures (Looser zones).

Personalize your experience

Follow Osteomalacia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it